ArticleJAMA oncology2023
Tissue-Based PD-L1 Expression Is the Strongest Predictor of Overall Survival Benefit From ICI in Advanced Gastroesophageal Cancer.
Xinmu Zhang et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it